2Bonadonna G, Moliterni A, Zambetti M, et al. 30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer: cohort study[J]. BMJ, 2005,330(7485): 217.
3Goldhirsch A, Wood WC, Gelber RD, et al.Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 [J]. Annals of Oncology,2007, 18(7): 1133-1144.
1Liu SV,Melstrom L,Yao K,et al.Neoadjuvant therapy for breast cancer.J Surg Oncol,2010,101:283-291.
2Barnadas A,Gil M,Sánchez-Rovira P,et al.Neoadjuvant endocrine therapy for breast cancer:past,present and future.Anticancer Drugs,2008,19:339-347.
3Macaskill EJ,Renshaw L,Dixon JM.Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer.Oncologist,2006,11:1081-1088.
4Fentiman IS,Christiaens MR,Paridaens R,et al.Treatment of operable breast cancer in the elderly:a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.Eur J Cancer,2003,39:309-316.
5Ma CX,Ellis MJ.Neoadjuvant endocrine therapy for locally advanced breast cancer.Semin Oncol,2006,33:650-656.
6Maeaskill EJ,Dixon JM.Neoadjuvant use of endocrine therapy in breast cancer.Breast J,2007,13:243-250.
7Horobin JM,Preece PE,Dewar JA,et al.Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only.Br J Surg,1991,78:213-217.
8Biganzoli L,Licitra S,Claudino W,et al.Clinical decision making in breast cancer:TAM and aromatase inhibitors for older patients:a jungle? Eur J Cancer,2007,43:2270-2278.
9Abrial C,Durando X,Mouret-Reynier MA,et al.Role of neoadjuvant hormonal therapy in the treatment of breast cancer:a review of clinical trials.Int J Gen Med,2009,2:129-140.
10Cataliotti L,Buzdar AU,Noguchi S,et al.Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer:the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.Cancer,2006,106:2095-2103.
